GeoVax Labs Inc (GOVX)

[remind2]

GOVX: How much is a 100% effective AIDS vax worth?

The genius vaccine developer, Dr. Thomas Monath, is now the Chairman of the GeoVax Science Advisory Board.

He made news a few weeks ago as the developer for NLNK & MRK of the first 100% effective Ebola vaccine.

In addition, GeoVax will be in San Francisco at the JP Morgan Conference from 1/9 to 1/12 meeting with potential partners and investors. This is the most important bio/pharma meeting of year.

Add to that the startup of the next round of AIDS human vaccinations this month and it is not hard to figure out which direction GOVX stock price is heading.

GeoVax could easily head multiples higher at any time. A puny $150 million dollar market cap makes GOVX a $3.00 stock.

The closely watch and highly influential Hal Mintz increased his GOVX stake 42% with news being posted after the close last Friday.

These names are huge.